Security key
00182C103
ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,453,052
- Total 13F value
- $319,499,983
- Share change
- +1,268,443
- Put/Call ratio
- 673%
- SEC-reported price per share
- $49.51
- Number of holders
- 151
- Value change
- +$59,803,632
- Number of buys
- 91
- Number of sells
- 60
- Shares outstanding
- 22,278,088
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
151
Top holders
10
ANIP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
ANI PHARMACEUTICALS INC SEC filings
ANI PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00182C103
Recent filing periods:
Ownership snapshot
Top reported holders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Fund Advisors
Disclosed value leader
BlackRock Fund Advisors
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 3.6%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Fund Advisors leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Fund Advisors's linked filing trail.
Comparable ownership
Top 5
BlackRock Fund Advisors
3.6%
Consonance Capital Management LP
2.2%
VANGUARD GROUP INC
1.9%
GLENMEDE TRUST CO NA
1.7%
STATE STREET CORP
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Fund Advisors |
13F
Company
|
3.6%
|
$48,173,000
794,666 shares
|
— | 31 Dec 2016 |
| Consonance Capital Management LP |
13F
Company
|
2.2%
|
$29,801,000
491,608 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$25,304,000
417,420 shares
|
— | 31 Dec 2016 |
| GLENMEDE TRUST CO NA |
13F
Company
|
1.7%
|
$23,097,000
381,031 shares
|
— | 31 Dec 2016 |
| STATE STREET CORP |
13F
Company
|
1.4%
|
$19,000,000
313,477 shares
|
— | 31 Dec 2016 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
1.2%
|
$16,192,000
267,100 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
151
Shares
6,453,052
Rows available
151
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
151
Q1 2017 holders
151
Holder diff
0
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend